ArticleBlood cancer journal2015

pVAX14DNA-mediated add-on immunotherapy combined with arsenic trioxide and all-trans retinoic acid targeted therapy effectively increases the survival of acute promyelocytic leukemia mice.

S Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.